We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Modifications Enhance Cancer-fighting Ability of Targeted siRNA

By LabMedica International staff writers
Posted on 09 Sep 2009
The possibility of treating cancers with targeted strands of RNA (small interfering RNA, or siRNA) that block the action of cancer-specific genes has been given a boost by the results of experiments to modify and enhance the activity of these compounds.

Investigators from the University of Iowa (Iowa City, USA) worked with a chimera, a synthetic molecule constructed from an aptamer (a small length of nucleic acid) specific for prostate-specific membrane antigen (PSMA), which is expressed by prostate cancer cells, and a siRNA directed against certain cancer genes. More...
They reported in the August 23, 2009, online edition of the journal Nature Biotechnology that modifications made to the chimera, including adding 2-nucleotide 3'-overhangs and optimizing the thermodynamic profile and structure of the molecule as well as reducing the length of the aptamer, increased the effectiveness of the compound. Furthermore, the addition of a polyethylene glycol moiety extended the chimeras' circulating half-life.

The new compound could be injected into the bloodstream rather than directly into the tumor. When this was done to a group of athymic mice carrying PSMA-expressing tumors, the chimeras caused pronounced regression of the tumors.

"Our goal was to make siRNA deliverable through the bloodstream and make it more specific to the genes that are overexpressed in cancer,” explained senior author Dr. Paloma Giangrande, assistant professor of internal medicine at the University of Iowa.

"If you want to use siRNA effectively for clinical use, especially for cancer treatment, you need to deliver it through an injection into the bloodstream, reduce the amount of side effects, and be able to improve its cost-effectiveness. Our findings may help make these things possible.”

Related Links:

University of Iowa


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Urinalysis Solution
UN-9000
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.